EP3759090A1 Novel Therapeutic Compounds by Inflazome Limited
Summary
The European Patent Office published patent application EP3759090A1 for novel therapeutic compounds filed by Inflazome Limited. The patent covers heterocyclic compounds with IPC classifications including C07D derivatives and A61P therapeutic activity (anti-inflammatory/analgesic). Designated states include all EU member states plus associated countries. The publication marks the grant of patent rights for these novel compounds.
What changed
EPO published patent application EP3759090A1, granting Inflazome Limited exclusive rights to novel therapeutic compounds with heterocyclic structures (C07D derivatives). The patent includes claims covering A61P 29/00 (anti-inflammatory and anti-rheumatic products) and A61K 31/4439 (pyridine derivatives).
Pharmaceutical manufacturers and drug developers should note this patent when conducting R&D in anti-inflammatory therapeutics. The designated state coverage across EU member states and associated countries provides broad geographic protection for the patented compounds.
What to do next
- Monitor patent portfolio for competitive intelligence
- Review compound claims for potential licensing opportunities
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NOVEL COMPOUNDS
Publication EP3759090A1 Kind: A1 Apr 08, 2026
Applicants
Inflazome Limited
Inventors
MILLER, David, VAN WILTENBURG, Jimmy, MEISSNER, Johannes Wilhem Georg, VAN HERPT, Jochem Theodoor, LION, Zhou Min, SHANNON, Jonathan, ST-GALLAY, Stephen, COOPER, Matthew
IPC Classifications
C07D 401/12 20060101AFI20190907BHEP C07D 213/71 20060101ALI20190907BHEP C07D 401/04 20060101ALI20190907BHEP C07D 405/12 20060101ALI20190907BHEP C07D 409/12 20060101ALI20190907BHEP C07D 409/14 20060101ALI20190907BHEP C07D 413/12 20060101ALI20190907BHEP C07D 417/12 20060101ALI20190907BHEP C07D 213/56 20060101ALI20190907BHEP C07D 213/64 20060101ALI20190907BHEP A61P 29/00 20060101ALI20190907BHEP A61K 31/4439 20060101ALI20190907BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.